Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Roe

Showing results (281-290 of 468) with videos related to

Pageof 47
Sort By:
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
The American Journal of Cardiology|November 7, 2009
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndromeNancy M Allen LaPointe, Anita Y Chen, Matthew T Roe, et al.
Circulation. Cardiovascular Quality and Outcomes|December 10, 2021
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical TrialGuillaume Marquis-Gravel, Bradley G Hammill, Hillary Mulder, et al.
JACC. Cardiovascular Interventions|April 20, 2010
Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)Shailja V Parikh, James A de Lemos, Michael E Jessen, et al.
Circulation|January 11, 2000
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT InvestigatorsS P Marso, D L Bhatt, M T Roe, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2019
Medication Discontinuation in the IMPROVE-IT TrialAnn Marie Navar, Matthew T Roe, Jennifer A White, et al.
American Heart Journal|September 24, 2016
The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline programMichael C Kontos, Tracy Y Wang, Anita Y Chen, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registryEmmanouil S Brilakis, Tracy Y Wang, Sunil V Rao, et al.
Indian Heart Journal|August 21, 2016
Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategyS A Wayangankar, M T Roe, A Y Chen, et al.
European Heart Journal. Acute Cardiovascular Care|August 1, 2015
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS TrialChiara Melloni, Jan H Cornel, Gail Hafley, et al.
Pageof 47

Showing results (281-290 of 468) with videos related to

Sort By:
Pageof 47
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
The American Journal of Cardiology|November 7, 2009
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndromeNancy M Allen LaPointe, Anita Y Chen, Matthew T Roe, et al.
Circulation. Cardiovascular Quality and Outcomes|December 10, 2021
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical TrialGuillaume Marquis-Gravel, Bradley G Hammill, Hillary Mulder, et al.
JACC. Cardiovascular Interventions|April 20, 2010
Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)Shailja V Parikh, James A de Lemos, Michael E Jessen, et al.
Circulation|January 11, 2000
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT InvestigatorsS P Marso, D L Bhatt, M T Roe, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2019
Medication Discontinuation in the IMPROVE-IT TrialAnn Marie Navar, Matthew T Roe, Jennifer A White, et al.
American Heart Journal|September 24, 2016
The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline programMichael C Kontos, Tracy Y Wang, Anita Y Chen, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registryEmmanouil S Brilakis, Tracy Y Wang, Sunil V Rao, et al.
Indian Heart Journal|August 21, 2016
Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategyS A Wayangankar, M T Roe, A Y Chen, et al.
European Heart Journal. Acute Cardiovascular Care|August 1, 2015
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS TrialChiara Melloni, Jan H Cornel, Gail Hafley, et al.
Pageof 47